SR One Capital Management — 2015 Investments

1 investments dated 2015 · listed companies and verified rows first · show all

Trivasculartrivascular.comin 𝕏Aug 2015SEC filingmedium confidence

Endologix develops medical devices for treating vascular disease, including the DETOUR™ System for endovascular aortic repair (EVAR) procedures.

HealthtechMedical DevicesSanta Rosa, US

DOUGLAS A. ROEDER(Director)SHARI L. O'QUINN(Executive Officer)MICHAEL V. CHOBOTOV(Executive Officer)MICHAEL R. KRAMER(Executive Officer)RYAN D. DRANT(Director)DANIEL J. MOORE(Director)

Board seatJake Nunn· per SEC Form D · $10M raise · filed Aug 2015

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.